policy – Biotechblog

Navigating the patentability of stem cells

This is a guest post from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology […]

Fortune magazine recently published an article on the growing trend of generic companies challenging pharmaceutical drug patents. I enjoyed working

The Center for Policy on Emerging Technologies, where I am on the board of directors, is hosting an Emerging Technologies

The Center for Policy on Emerging Technologies, where I am on the board of directors, is hosting an Emerging Technologies

My most recent editorial in the Journal of Commercial Biotechnology, “The impact of the global financial crisis on biotechnology development,”